Drug Shortage Report for INTEGRILIN

Last updated on 2017-08-10 History
Report ID 9382
Drug Identification Number 02240352
Brand name INTEGRILIN
Common or Proper name Eptifibatide Injection
Company Name MERCK CANADA INC
Market Status MARKETED
Active Ingredient(s) EPTIFIBATIDE
Strength(s) 2MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 20MG/10ML vial
ATC code B01AC
ATC description ANTITHROMBOTIC AGENTS
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2017-07-05
Estimated end date 2017-08-11
Actual end date 2017-08-09
Shortage status Resolved
Updated date 2017-08-10
Company comments
Health Canada comments
Contact Address 16750 ROUTE TRANSCANADIENNE
KIRKLAND, QUEBEC
CANADA H9H 4M7
Company contact information 1-800-567-2594 medinfocanada@merck.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v25 2017-08-10 English Compare
v24 2017-08-09 French Compare
v23 2017-08-09 English Compare
v22 2017-07-24 French Compare
v21 2017-07-24 English Compare
v20 2017-07-12 English Compare
v19 2017-07-06 English Compare
v18 2017-07-05 English Compare
v17 2017-06-27 English Compare
v16 2017-06-19 English Compare
v15 2017-06-19 English Compare
v14 2017-06-19 French Compare
v13 2017-06-19 English Compare
v12 2017-06-19 French Compare
v11 2017-06-12 French Compare
v10 2017-06-12 English Compare
v9 2017-06-05 French Compare
v8 2017-06-05 English Compare
v7 2017-05-30 French Compare
v6 2017-05-29 French Compare

Showing 1 to 20 of 25